Despite the low frequencies of CNV of the hub genes in PRAD, survival analysis predicted a shorter survival duration for those cohorts having CNV of OBSCN and LIN9 (Figure 5H). This evidence concerns the gene OBSCN and prostate adenocarcinoma.